Business Wire

NTT DOCOMO BUSINESS and NTT Com Asia Launch “APN InterLink” Service in Hong Kong

24.10.2025 06:00:00 CEST | Business Wire | Press Release

Share

NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation, hereafter “NTT DOCOMO BUSINESS”) and its Hong Kong subsidiary, NTT Com Asia, today announced the launch of the “APN InterLink” service in Hong Kong for financial institutions starting November 1, 2025, leveraging All-Photonic Network (APN)*1 technology in support of the IOWN®*2 initiative. Commercially deployed in Hong Kong, one of the leading Asia financial hubs, the new service leverages ultra-low latency photonics-based connectivity to address the evolving digital needs of the financial sector, especially for latency-sensitive trading, algorithmic trading*3, proximity market data access and real-time transaction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023916941/en/

NTT APN InterLink Service

Looking ahead, NTT DOCOMO BUSINESS and NTT Com Asia plan to expand the deployment of IOWN® APN on the Asia Submarine-cable Express (ASE), which connects Tokyo and Hong Kong, to enable seamless collaboration between major financial centers.

1. Background

The financial industry is experiencing rapid digital transformation, driving the need for faster and more sophisticated transactions. Algorithmic trading and other latency-sensitive trading, such as High Frequency Trading (HFT), as well as real-time transaction, are on the rise, making ultra-low latency networks essential for financial institutions to maintain a competitive edge—where even milliseconds can impact trading outcomes. With APN InterLink, financial institutions can accelerate their digital transformation and strengthen their foundation for innovation, including collaborative development and AI-driven initiatives.

For mission-critical operations, robust disaster recovery systems are vital to ensure business continuity in the face of severe disruptions. By leveraging IOWN® APN, organizations can achieve efficient, seamless data transmission between geographically distributed sites, significantly enhancing the reliability and operational efficiency of large-scale disaster countermeasures.

2.Service Overview

APN InterLink offers the following connectivity solutions for the financial services industry:

  1. APN Connection between Data Centers (APN DCLink):
    The interconnection between NTT Com Asia’s Financial Data Center and Tai Po Data Center via APN delivers an ultra-low latency network. With the Financial Data Center is located in close proximity to the Hong Kong Stock Exchange (HKEX), the interconnection ensures optimal performance for mission-critical financial operations such as latency-sensitive trading and real-time transaction processing.

  2. Connection between Any Locations (APN DedicatedLink):
    APN DedicatedLink enables seamless connections between any customer facilities or data centers within Hong Kong. Customers can connect their sites to the FDC and TPDC, achieving ultra-low latency access to the HKEX.

3.Future Developments

To meet the growing demand for low-latency connectivity between Japan and Hong Kong, NTT DOCOMO BUSINESS offers “docomo business APN Plus powered by IOWN®”*4 (hereafter “docomo business APN Plus”) in Japan, whereas NTT Com Asia offers “APN InterLink” in Hong Kong, enabling high-speed access in both markets.

NTT DOCOMO BUSINESS and NTT Com Asia plan to further expand APN deployment on the ASE cable connecting Tokyo and Hong Kong, and establish IOWN® APN hubs throughout Asia. This initiative will facilitate seamless collaboration between major financial centers and accelerating digital transformation in the financial industry.

4.Endorsements

“NTT DOCOMO BUSINESS is providing the IOWN® APN service 'docomo business APN Plus' in Japan, which has been well received by many customers. We are actively working to connect 'APN InterLink', set for commercial deployment in Hong Kong, with Japan’s 'docomo business APN Plus' to deliver the service globally. Through this initiative, we aim to further support our customers’ mission-critical applications and business operations.”
— Hisashi Fujishima, Senior Executive Officer, Head of Platform Services Division, NTT DOCOMO BUSINESS

“We are pleased to launch APN InterLink in Hong Kong, one of the world’s leading financial hubs. Leveraging the latest IOWN® technology, we are committed to building next-generation infrastructure for the financial industry.”
— Daisuke Kuroda, CEO, NTT Com Asia Ltd.

5.Roles of Each Company

NTT DOCOMO BUSINESS: Provides the APN service “docomo business APN Plus”, and manages sales operations in Japan.
NTT Com Asia: Provides the APN service “APN InterLink”, and manages sales operations in Hong Kong.

6.Pricing and Application

For pricing and application details, please contact the sales representatives at NTT DOCOMO BUSINESS or NTT Com Asia.

7. About IOWN APN

IOWN®, a groundbreaking initiative with the mission to revolutionizing network architecture and smart infrastructure, is led by NTT Group and IOWN Global Forum which comprises over 170 member organizations from 19 countries from leaders in telecommunications, cloud computing, semiconductors. At its core is the APN, which replaces conventional electronic transmission with optical communication and software integration.

This paradigm shift leverages high capacity, ultra low-latency and energy-efficient photonic-based connectivity to enable transformative capabilities across industries — fulfilling ESG commitments and empowering real-time data processing, intelligent automation, and sustainable digital transformation.

NTT Communications Corporation changed its name to NTT DOCOMO BUSINESS, Inc. on July 1, 2025. As an Industrial and Regional DX Platformer that drives digital transformation across industries and communities, we are enabling the development of a decentralized, autonomous, and collaborative society where businesses and communities can thrive sustainably. Our mission is to unlock new value and help create prosperity for all.

https://www.ntt.com/en/index.html

*1:

APN: An all-photonics network introducing photonics-based technology to everything from networks to terminals.

*2:

IOWN®: A network and information processing platform utilizing photonics and information processing technologies to realize a smart society. “IOWN®” is a trademark or registered trademark of NTT Corporation.

*3:

Algorithmic trading refers to trading in which computers automatically determine the timing and quantity of stock orders and repeatedly place them.

*4:

docomo business APN Plus powered by IOWN®: A high-capacity, low-latency, stable network service based on the IOWN® initiative.

https://www.ntt.com/about-us/press-releases/news/article/2025/0918.html

*docomo business APN Plus is a trademark pending registration by NTT DOCOMO BUSINESS.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251023916941/en/

Contacts

[Contact Information]
Platform Service division, Cloud & Network services,
Sales promotion
Contact us through the inquiry form -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ntt.com%2F
business%2Fcontact.html&esheet=54343189&newsitemid=20251023916941&lan=en-US&anch
or=Contact+us+through+the+inquiry+form&index=8&md5=b052a9b7e564c3c8971e25910bc67
d0d

NTT Com Asia
Marketing Department
ML: hk.marketing@ntt.com.hk

Contact information for inquiries from the media
NTT DOCOMO BUSINESS, Inc.
Corporate Planning Department Public Relations Office
ML: pr-cp@ntt.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye